{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:42:36Z","timestamp":1786714956724,"version":"build-2736575974"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol India"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0028-3886.177630","type":"journal-article","created":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T00:04:36Z","timestamp":1457049876000},"page":"279","source":"Crossref","is-referenced-by-count":2,"title":["Molecular predictive and prognostic factors in ependymoma"],"prefix":"10.4103","volume":"64","author":[{"given":"Supriya","family":"Mallick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rony","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PramodK","family":"Julka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GouraK","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0028-3886.177630-1","first-page":"111","volume-title":", Nisen PD.Infrequency of p53 gene mutations in ependymomas","author":"Fink","year":"1996","journal-title":"J Neurooncol"},{"key":"key-10.4103\/0028-3886.177630-2","first-page":"725","volume-title":"Incidence patterns for ependymoma: A surveillance, epidemiology, and end results study","author":"McGuire","year":"2009","journal-title":"J Neurosurg"},{"key":"key-10.4103\/0028-3886.177630-3","first-page":"79","volume-title":"Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group","author":"Perilongo","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"key-10.4103\/0028-3886.177630-4","first-page":"117","volume-title":"Intracranial ependymomas: An analysis of prognostic factors and patterns of failure","author":"Paulino","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"key-10.4103\/0028-3886.177630-5","first-page":"135","volume-title":"Prognostic factors in childhood intracranial ependymomas: The role of age and tumor location","author":"Sala","year":"1998","journal-title":"Pediatr Neurosurg"},{"key":"key-10.4103\/0028-3886.177630-6","first-page":"606","volume-title":"Timing of adjuvant radiotherapy and treatment outcome in childhood ependymoma","author":"Liu","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.4103\/0028-3886.177630-7","first-page":"845","volume-title":", Buatti JM, McCollough WM, Mickle JP, Kedar A, et al. Ependymoma: Results, prognostic factors and treatment recommendations","author":"McLaughlin","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.4103\/0028-3886.177630-8","first-page":"980","volume-title":"Pediatric intracranial ependymomas: Prognostic relevance of histological, immunohistochemical, and flow cytometric factors","author":"Zamecnik","year":"2003","journal-title":"Mod Pathol"},{"key":"key-10.4103\/0028-3886.177630-9","first-page":"867","volume-title":"Surveying and optimizing the predictors for ependymoma specific survival using SEER data","author":"Cheung","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"key-10.4103\/0028-3886.177630-10","first-page":"679","volume-title":"Prognostic factors and results after the combined surgical and radiotherapy treatment of ependymomas","author":"Grabenbauer","year":"1992","journal-title":"Strahlenther Onkol"},{"key":"key-10.4103\/0028-3886.177630-11","first-page":"319","volume-title":"Intracranial ependymomas in children: A critical review of prognostic factors and a plea for cooperation","author":"Bouffet","year":"1998","journal-title":"Med Pediatr Oncol"},{"key":"key-10.4103\/0028-3886.177630-12","first-page":"1183","volume-title":", Selch MT, Holmes E, Berger MS, Finlay JL, Flannery A, et al. Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma","author":"Garvin","year":"39;s","journal-title":"Children"},{"key":"key-10.4103\/0028-3886.177630-13","first-page":"215","volume-title":"Prognostic factors in infants and very young children with intracranial ependymomas","author":"Duffner","year":"1998","journal-title":"Pediatr Neurosurg"},{"key":"key-10.4103\/0028-3886.177630-14","first-page":"11","volume-title":"Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry","author":"Prayson","year":"1999","journal-title":"Ann Diagn Pathol"},{"key":"key-10.4103\/0028-3886.177630-15","first-page":"434","volume-title":"Ki-67 immunolabelling index is a prognostic indicator in childhood posterior fossa ependymomas","author":"Bennetto","year":"1998","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key-10.4103\/0028-3886.177630-16","first-page":"675","volume-title":"Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma","author":"Ridley","year":"2008","journal-title":"Neuro Oncol"},{"key":"key-10.4103\/0028-3886.177630-17","first-page":"483","volume-title":"Genomic characterization of ependymomas reveals 6q loss as the most common aberration","author":"Olsen","year":"2014","journal-title":"Oncol Rep"},{"key":"key-10.4103\/0028-3886.177630-18","first-page":"357","volume-title":"Human ependymomas reveal frequent deletions on chromosomes 6 and 9","author":"Huang","year":"2003","journal-title":"Acta Neuropathol"},{"key":"key-10.4103\/0028-3886.177630-19","first-page":"18","volume-title":"Comparative genomic hybridization detects losses of chromosomes 22 and 16 as the most common recurrent genetic alterations in primary ependymomas","author":"Zheng","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"key-10.4103\/0028-3886.177630-20","first-page":"415","volume-title":"Loss of heterozygosity on chromosome 22 in human ependymomas","author":"Huang","year":"2002","journal-title":"Acta Neuropathol"},{"key":"key-10.4103\/0028-3886.177630-21","first-page":"1150","volume-title":"Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2","author":"Hulsebos","year":"1999","journal-title":"Br J Cancer"},{"key":"key-10.4103\/0028-3886.177630-22","first-page":"9","volume-title":"Identification of novel regions of allelic loss in ependymomas by high-resolution allelotyping with 384 microsatellite markers","author":"Tong","year":"2001","journal-title":"J Neurosurg"},{"key":"key-10.4103\/0028-3886.177630-23","first-page":"627","volume-title":"Molecular genetic analysis of ependymal tumors.NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas","author":"Ebert","year":"1999","journal-title":"Am J Pathol"},{"key":"key-10.4103\/0028-3886.177630-24","first-page":"1137","volume-title":"Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups","author":"Hirose","year":"2001","journal-title":"Am J Pathol"},{"key":"key-10.4103\/0028-3886.177630-25","first-page":"803","volume-title":"Molecular genetic alterations on chromosomes 11 and 22 in ependymomas","author":"Lamszus","year":"2001","journal-title":"Int J Cancer"},{"key":"key-10.4103\/0028-3886.177630-26","first-page":"1136","volume-title":"Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma","author":"Rand","year":"2008","journal-title":"Br J Cancer"},{"key":"key-10.4103\/0028-3886.177630-27","first-page":"2070","volume-title":"Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma","author":"Mendrzyk","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/0028-3886.177630-28","first-page":"72","volume-title":"Immunohistochemical markers for intracranial ependymoma recurrence.An analysis of 88 cases","author":"Korshunov","year":"2000","journal-title":"J Neurol Sci"},{"key":"key-10.4103\/0028-3886.177630-29","first-page":"255","volume-title":"Immunohistochemical markers for prognosis of ependymal neoplasms","author":"Korshunov","year":"2002","journal-title":"J Neurooncol"},{"key":"key-10.4103\/0028-3886.177630-30","first-page":"267","volume-title":"Study of chromosome 9q gain, notch pathway regulators and tenascin-C in ependymomas","author":"Gupta","year":"2014","journal-title":"J Neurooncol"},{"key":"key-10.4103\/0028-3886.177630-31","first-page":"714","volume-title":"Study of stem cell marker nestin and its correlation with vascular endothelial growth factor and microvascular density in ependymomas","author":"Nambirajan","year":"2014","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key-10.4103\/0028-3886.177630-32","first-page":"291","volume-title":"Rare occurrence of inactivating p53 gene mutations in primary non-astrocytic tumors of the central nervous system: Reappraisal by yeast functional assay","author":"Nozaki","year":"1998","journal-title":"Acta Neuropathol"},{"key":"key-10.4103\/0028-3886.177630-33","first-page":"464","volume-title":"Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype","author":"Rushing","year":"1998","journal-title":"Mod Pathol"},{"key":"key-10.4103\/0028-3886.177630-34","first-page":"991","volume-title":"Alterations of protein 4.1 family members in ependymomas: A study of 84 cases","author":"Rajaram","year":"2005","journal-title":"Mod Pathol"},{"key":"key-10.4103\/0028-3886.177630-35","first-page":"1743","volume-title":"Nuclear expression of survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade","author":"Altura","year":"2003","journal-title":"Br J Cancer"},{"key":"key-10.4103\/0028-3886.177630-36","first-page":"543","volume-title":"Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome","author":"Preusser","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"key-10.4103\/0028-3886.177630-37","first-page":"3054","volume-title":"ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease","author":"Gilbertson","year":"2002","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/0028-3886.177630-38","first-page":"699","volume-title":"Expression of mos in ependymal gliomas","author":"Athanasiou","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"key-10.4103\/0028-3886.177630-39","first-page":"542","volume-title":"Analysis of HIC-1 methylation and transcription in human ependymomas","author":"Waha","year":"2004","journal-title":"Int J Cancer"},{"key":"key-10.4103\/0028-3886.177630-40","first-page":"574","volume-title":"CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours","author":"Rousseau","year":"2003","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key-10.4103\/0028-3886.177630-41","first-page":"1721","volume-title":"Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age","author":"Korshunov","year":"2003","journal-title":"Am J Pathol"},{"key":"key-10.4103\/0028-3886.177630-42","first-page":"5223","volume-title":"Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics","author":"Modena","year":"2006","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0028-3886.177630-43","first-page":"560","volume-title":"Unique molecular characteristics of pediatric myxopapillary ependymoma","author":"Barton","year":"2010","journal-title":"Brain Pathol"},{"key":"key-10.4103\/0028-3886.177630-44","first-page":"415","volume-title":"Symptomatic subependymomas of the ventricles.Review of twenty consecutive cases","author":"Vitanovics","year":"2014","journal-title":"Ideggyogy Sz"},{"key":"key-10.4103\/0028-3886.177630-45","first-page":"325","volume-title":"Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival","author":"Lukashova-v","year":"2007","journal-title":"Acta Neuropathol"},{"key":"key-10.4103\/0028-3886.177630-46","first-page":"1424","volume-title":"Prognostic relevance of global histone 3 lysine 9 acetylation in ependymal tumors","author":"Ebrahimi","year":"2013","journal-title":"J Neurosurg"},{"key":"key-10.4103\/0028-3886.177630-47","first-page":"66","volume-title":"Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype","author":"Suri","year":"2004","journal-title":"Indian J Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0019-509X","issn-type":"print"},{"key":"key-10.4103\/0028-3886.177630-48","first-page":"958","volume-title":"Chromosomal imbalances in clear cell ependymomas","author":"Rickert","year":"2006","journal-title":"Mod Pathol"},{"key":"key-10.4103\/0028-3886.177630-49","first-page":"929","volume-title":"Genetic abnormalities detected in ependymomas by comparative genomic hybridisation","author":"Carter","year":"2002","journal-title":"Br J Cancer"},{"key":"key-10.4103\/0028-3886.177630-50","first-page":"143","volume-title":"Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma","author":"Witt","year":"2011","journal-title":"Cancer Cell"},{"key":"key-10.4103\/0028-3886.177630-51","first-page":"451","volume-title":"C11orf95-RELA fusions drive oncogenic NF-\u03baB signalling in ependymoma","author":"Parker","year":"2014","journal-title":"Nature"},{"key":"key-10.4103\/0028-3886.177630-52","first-page":"728","volume-title":"Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups","author":"Pajtler","year":"2015","journal-title":"Cancer Cell"},{"key":"key-10.4103\/0028-3886.177630-53","first-page":"613","volume-title":"Defining the molecular landscape of ependymomas","author":"Archer","year":"2015","journal-title":"Cancer Cell"},{"key":"key-10.4103\/0028-3886.177630-54","first-page":"765","volume-title":"Pediatric ependymoma: Biological perspectives","author":"Kilday","year":"2009","journal-title":"Mol Cancer Res"},{"key":"key-10.4103\/0028-3886.177630-55","first-page":"107","volume-title":"Complex cytogenetic abnormalities including telomeric associations and MEN1 mutation in a pediatric ependymoma","author":"Urioste","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"key-10.4103\/0028-3886.177630-56","first-page":"754","volume-title":"The significance of human telomerase reverse transcriptase (hTERT) in cancer","author":"Kirkpatrick","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"key-10.4103\/0028-3886.177630-57","first-page":"1522","volume-title":"Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma","author":"Tabori","year":"2006","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0028-3886.177630-58","first-page":"37","volume-title":"Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas","author":"von","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"key-10.4103\/0028-3886.177630-59","first-page":"604","volume-title":"p53 Pathway dysfunction in primary childhood ependymomas","author":"Gaspar","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.4103\/0028-3886.177630-60","first-page":"997","volume-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","author":"Hegi","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0028-3886.177630-61","first-page":"263","volume-title":"O6-methylguanine-DNA-methyltransferase in recurring anaplastic ependymomas: PCR and immunohistochemistry","author":"Buccoliero","year":"2008","journal-title":"J Chemother"},{"key":"key-10.4103\/0028-3886.177630-62","first-page":"219","volume-title":"Prognostic value of immunoexpression of the chemoresistance-related proteins in ependymomas: An analysis of 76 cases","author":"Korshunov","year":"1999","journal-title":"J Neurooncol"}],"container-title":["Neurology India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:23:28Z","timestamp":1786713808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.177630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"alternative-id":["177630"],"URL":"https:\/\/doi.org\/10.4103\/0028-3886.177630","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}